Stratos Wealth Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Stratos Wealth Advisors’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,329	Closed	-$275K	–	631
2025 Q4	$275K	Buy	+1,329	New	+$266K	0.01%	544
2025 Q2	–	Sell	-1,450	Closed	-$247K	–	685
2025 Q1	$247K	Buy	+1,450	New	+$252K	0.01%	582
2024 Q4	–	Sell	-1,522	Closed	-$262K	–	735
2024 Q3	$262K	Buy	+1,522	New	+$252K	0.01%	637
2020 Q2	–	Sell	-50	Closed	-$7K	–	290
2020 Q1	$7K	Buy	+50	New	+$7.12K	0.01%	250
2019 Q4	–	Sell	-8,356	Closed	-$1.03M	–	190
2019 Q3	$1.03M	Sell	8,356 -695	-8%	-$92.5K	0.4%	69
2019 Q2	$1.27M	Buy	9,051 +158	+2%	+$21.8K	0.51%	46
2019 Q1	$1.34M	Buy	+8,893	New	+$1.28M	0.73%	32

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Stratos Wealth Advisors's FBT Position: Q1 2026 in Review

Stratos Wealth Advisors sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2026, closing a stake of 1,329 shares — an estimated $275K sold.

Stratos Wealth Advisors first reported a position in FBT in Q1 2019 and held it in 7 quarters. The position peaked at $1.34M in Q1 2019. 308 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

Stratos Wealth Advisors reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2026 after selling out during the quarter.
Stratos Wealth Advisors sold 1,329 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $275K.
Stratos Wealth Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2019 and held it in 7 quarters.
Stratos Wealth Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.34M in Q1 2019.
308 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Stratos Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.